The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Metabolic Syndrome-Global Market Insights and Sales Trends 2025
Synopsis
Metabolic syndrome is a cluster of conditions — increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels — that occur together, increasing your risk of heart disease, stroke and diabetes.
The global Metabolic Syndrome market size is expected to reach US$ 34940 million by 2029, growing at a CAGR of 5.1% from 2023 to 2029. The market is mainly driven by the significant applications of Metabolic Syndrome in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Metabolic Syndrome market. Diabetes, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Obesity segment is estimated at % CAGR for the next seven-year period.
One of the upcoming trends gaining traction in the market is the increasing focus on oral insulin therapies. Till now, insulin injections were mostly administered through subcutaneous tissues, but this route of application is associated with risk of infection and hypersensitivity reactions, emboli, high cost, and injection site pain. Also, several needle-phobic individuals hesitate to adopt this route of administration. This paved the way for extensive research in the development of oral insulin. The oral form of insulin prevents the unpleasantness of insulin injections and other complications associated with the existing therapies. Moreover, oral administration of insulin ensures increased patient comfort and compliance, reduced risk of infection, simpler application, and is cost-effective.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Metabolic Syndrome, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Metabolic Syndrome market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Metabolic Syndrome market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Metabolic Syndrome sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Metabolic Syndrome covered in this report include Novo Nordisk, Sanofi, Merck, AstraZeneca, Eli Lily, AbbVie, Actelion Pharmaceuticals, Adocia and Aegerion Pharmaceuticals, etc.
The global Metabolic Syndrome market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novo Nordisk
Sanofi
Merck
AstraZeneca
Eli Lily
AbbVie
Actelion Pharmaceuticals
Adocia
Aegerion Pharmaceuticals
Akros Pharma
Alnylam Pharmaceuticals
Amarin
nAmgen
Amicus Therapeutics
Arbutus Biopharma
Global Metabolic Syndrome market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Metabolic Syndrome market, Segment by Type:
Diabetes
Obesity
Hypercholesterolemia
Lysosomal storage diseases
Global Metabolic Syndrome market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Metabolic Syndrome companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Metabolic syndrome is a cluster of conditions — increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels — that occur together, increasing your risk of heart disease, stroke and diabetes.
The global Metabolic Syndrome market size is expected to reach US$ 34940 million by 2029, growing at a CAGR of 5.1% from 2023 to 2029. The market is mainly driven by the significant applications of Metabolic Syndrome in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Metabolic Syndrome market. Diabetes, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Obesity segment is estimated at % CAGR for the next seven-year period.
One of the upcoming trends gaining traction in the market is the increasing focus on oral insulin therapies. Till now, insulin injections were mostly administered through subcutaneous tissues, but this route of application is associated with risk of infection and hypersensitivity reactions, emboli, high cost, and injection site pain. Also, several needle-phobic individuals hesitate to adopt this route of administration. This paved the way for extensive research in the development of oral insulin. The oral form of insulin prevents the unpleasantness of insulin injections and other complications associated with the existing therapies. Moreover, oral administration of insulin ensures increased patient comfort and compliance, reduced risk of infection, simpler application, and is cost-effective.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Metabolic Syndrome, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Metabolic Syndrome market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Metabolic Syndrome market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Metabolic Syndrome sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Metabolic Syndrome covered in this report include Novo Nordisk, Sanofi, Merck, AstraZeneca, Eli Lily, AbbVie, Actelion Pharmaceuticals, Adocia and Aegerion Pharmaceuticals, etc.
The global Metabolic Syndrome market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novo Nordisk
Sanofi
Merck
AstraZeneca
Eli Lily
AbbVie
Actelion Pharmaceuticals
Adocia
Aegerion Pharmaceuticals
Akros Pharma
Alnylam Pharmaceuticals
Amarin
nAmgen
Amicus Therapeutics
Arbutus Biopharma
Global Metabolic Syndrome market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Metabolic Syndrome market, Segment by Type:
Diabetes
Obesity
Hypercholesterolemia
Lysosomal storage diseases
Global Metabolic Syndrome market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Metabolic Syndrome companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Metabolic Syndrome
1.1 Metabolic Syndrome Market Overview
1.1.1 Metabolic Syndrome Product Scope
1.1.2 Metabolic Syndrome Market Status and Outlook
1.2 Global Metabolic Syndrome Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Metabolic Syndrome Market Size by Region (2018-2029)
1.4 Global Metabolic Syndrome Historic Market Size by Region (2018-2023)
1.5 Global Metabolic Syndrome Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Metabolic Syndrome Market Size (2018-2029)
1.6.1 North America Metabolic Syndrome Market Size (2018-2029)
1.6.2 Europe Metabolic Syndrome Market Size (2018-2029)
1.6.3 Asia-Pacific Metabolic Syndrome Market Size (2018-2029)
1.6.4 Latin America Metabolic Syndrome Market Size (2018-2029)
1.6.5 Middle East & Africa Metabolic Syndrome Market Size (2018-2029)
2 Metabolic Syndrome Market by Type
2.1 Introduction
2.1.1 Diabetes
2.1.2 Obesity
2.1.3 Hypercholesterolemia
2.1.4 Lysosomal storage diseases
2.2 Global Metabolic Syndrome Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Metabolic Syndrome Historic Market Size by Type (2018-2023)
2.2.2 Global Metabolic Syndrome Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Metabolic Syndrome Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Metabolic Syndrome Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Metabolic Syndrome Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Metabolic Syndrome Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Metabolic Syndrome Revenue Breakdown by Type (2018-2029)
3 Metabolic Syndrome Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Metabolic Syndrome Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Metabolic Syndrome Historic Market Size by Application (2018-2023)
3.2.2 Global Metabolic Syndrome Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Metabolic Syndrome Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Metabolic Syndrome Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Metabolic Syndrome Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Metabolic Syndrome Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Metabolic Syndrome Revenue Breakdown by Application (2018-2029)
4 Metabolic Syndrome Competition Analysis by Players
4.1 Global Metabolic Syndrome Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Metabolic Syndrome as of 2022)
4.3 Date of Key Players Enter into Metabolic Syndrome Market
4.4 Global Top Players Metabolic Syndrome Headquarters and Area Served
4.5 Key Players Metabolic Syndrome Product Solution and Service
4.6 Competitive Status
4.6.1 Metabolic Syndrome Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Novo Nordisk
5.1.1 Novo Nordisk Profile
5.1.2 Novo Nordisk Main Business
5.1.3 Novo Nordisk Metabolic Syndrome Products, Services and Solutions
5.1.4 Novo Nordisk Metabolic Syndrome Revenue (US$ Million) & (2018-2023)
5.1.5 Novo Nordisk Recent Developments
5.2 Sanofi
5.2.1 Sanofi Profile
5.2.2 Sanofi Main Business
5.2.3 Sanofi Metabolic Syndrome Products, Services and Solutions
5.2.4 Sanofi Metabolic Syndrome Revenue (US$ Million) & (2018-2023)
5.2.5 Sanofi Recent Developments
5.3 Merck
5.3.1 Merck Profile
5.3.2 Merck Main Business
5.3.3 Merck Metabolic Syndrome Products, Services and Solutions
5.3.4 Merck Metabolic Syndrome Revenue (US$ Million) & (2018-2023)
5.3.5 AstraZeneca Recent Developments
5.4 AstraZeneca
5.4.1 AstraZeneca Profile
5.4.2 AstraZeneca Main Business
5.4.3 AstraZeneca Metabolic Syndrome Products, Services and Solutions
5.4.4 AstraZeneca Metabolic Syndrome Revenue (US$ Million) & (2018-2023)
5.4.5 AstraZeneca Recent Developments
5.5 Eli Lily
5.5.1 Eli Lily Profile
5.5.2 Eli Lily Main Business
5.5.3 Eli Lily Metabolic Syndrome Products, Services and Solutions
5.5.4 Eli Lily Metabolic Syndrome Revenue (US$ Million) & (2018-2023)
5.5.5 Eli Lily Recent Developments
5.6 AbbVie
5.6.1 AbbVie Profile
5.6.2 AbbVie Main Business
5.6.3 AbbVie Metabolic Syndrome Products, Services and Solutions
5.6.4 AbbVie Metabolic Syndrome Revenue (US$ Million) & (2018-2023)
5.6.5 AbbVie Recent Developments
5.7 Actelion Pharmaceuticals
5.7.1 Actelion Pharmaceuticals Profile
5.7.2 Actelion Pharmaceuticals Main Business
5.7.3 Actelion Pharmaceuticals Metabolic Syndrome Products, Services and Solutions
5.7.4 Actelion Pharmaceuticals Metabolic Syndrome Revenue (US$ Million) & (2018-2023)
5.7.5 Actelion Pharmaceuticals Recent Developments
5.8 Adocia
5.8.1 Adocia Profile
5.8.2 Adocia Main Business
5.8.3 Adocia Metabolic Syndrome Products, Services and Solutions
5.8.4 Adocia Metabolic Syndrome Revenue (US$ Million) & (2018-2023)
5.8.5 Adocia Recent Developments
5.9 Aegerion Pharmaceuticals
5.9.1 Aegerion Pharmaceuticals Profile
5.9.2 Aegerion Pharmaceuticals Main Business
5.9.3 Aegerion Pharmaceuticals Metabolic Syndrome Products, Services and Solutions
5.9.4 Aegerion Pharmaceuticals Metabolic Syndrome Revenue (US$ Million) & (2018-2023)
5.9.5 Aegerion Pharmaceuticals Recent Developments
5.10 Akros Pharma
5.10.1 Akros Pharma Profile
5.10.2 Akros Pharma Main Business
5.10.3 Akros Pharma Metabolic Syndrome Products, Services and Solutions
5.10.4 Akros Pharma Metabolic Syndrome Revenue (US$ Million) & (2018-2023)
5.10.5 Akros Pharma Recent Developments
5.11 Alnylam Pharmaceuticals
5.11.1 Alnylam Pharmaceuticals Profile
5.11.2 Alnylam Pharmaceuticals Main Business
5.11.3 Alnylam Pharmaceuticals Metabolic Syndrome Products, Services and Solutions
5.11.4 Alnylam Pharmaceuticals Metabolic Syndrome Revenue (US$ Million) & (2018-2023)
5.11.5 Alnylam Pharmaceuticals Recent Developments
5.12 Amarin
5.12.1 Amarin Profile
5.12.2 Amarin Main Business
5.12.3 Amarin Metabolic Syndrome Products, Services and Solutions
5.12.4 Amarin Metabolic Syndrome Revenue (US$ Million) & (2018-2023)
5.12.5 Amarin Recent Developments
5.13 nAmgen
5.13.1 nAmgen Profile
5.13.2 nAmgen Main Business
5.13.3 nAmgen Metabolic Syndrome Products, Services and Solutions
5.13.4 nAmgen Metabolic Syndrome Revenue (US$ Million) & (2018-2023)
5.13.5 nAmgen Recent Developments
5.14 Amicus Therapeutics
5.14.1 Amicus Therapeutics Profile
5.14.2 Amicus Therapeutics Main Business
5.14.3 Amicus Therapeutics Metabolic Syndrome Products, Services and Solutions
5.14.4 Amicus Therapeutics Metabolic Syndrome Revenue (US$ Million) & (2018-2023)
5.14.5 Amicus Therapeutics Recent Developments
5.15 Arbutus Biopharma
5.15.1 Arbutus Biopharma Profile
5.15.2 Arbutus Biopharma Main Business
5.15.3 Arbutus Biopharma Metabolic Syndrome Products, Services and Solutions
5.15.4 Arbutus Biopharma Metabolic Syndrome Revenue (US$ Million) & (2018-2023)
5.15.5 Arbutus Biopharma Recent Developments
6 North America
6.1 North America Metabolic Syndrome Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Metabolic Syndrome Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Metabolic Syndrome Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Metabolic Syndrome Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Metabolic Syndrome Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Metabolic Syndrome Market Dynamics
11.1 Metabolic Syndrome Industry Trends
11.2 Metabolic Syndrome Market Drivers
11.3 Metabolic Syndrome Market Challenges
11.4 Metabolic Syndrome Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
